Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Faron Pharmaceuticals Share News (FARN)
FARN Share
Price
FARN Share
News
FARN Share
Chat
FARN Share
Trades8
FARN
Live RNS
FARN Share
Charts
FARN Level 2
Console
FARN Live
Share Price
FARN Broker
Ratings
FARN Directors
Deals
FARN Financial
Diary
FARN
Fundamentals
FARN Short
Positions
FARN
Media
FARN Company
Research
FARN Company
Timeline
Share Price Information for Faron Pharmaceuticals (FARN)
Last checked at -
Last checked at 
Intraday Faron Pharmaceuticals Share Chart
Faron Pharmaceuticals Notes Study Supporting Clevegen Programme
LONDON (Alliance News) - Faron Pharmaceuticals Oy on Monday said an article published in the Journal of Immunology has outlined the functional role of the company's Clever-1 treatment, part of its Clevegen cancer immunotherapy antibody programme.
Faron, which floated in London earlier this month, said the data published in the study supported Clever-1 as an immuosuppresive molecule and supports the use of Clevegen as an immunotherapy product.
"We are working hard to advance our Clevegen programme, as announced recently, towards clinical use as a new onco-immunological alternative," said Faron Chief Executive Markku Jalkanen.
Shares in Faron were trading flat at 275.00 pence on Monday.
By Sam Unsted; samunsted@alliancenews.com; @SamUAtAlliance
Copyright 2015 Alliance News Limited. All Rights Reserved.
Latest FARN News
- TRADING UPDATES: Wey takeover edges closer; Acorn in strategy switch
17 May 2021 - Faron Pharmaceuticals reports 'promising' data from drug study
17 May 2021 - Faron Pharmaceuticals gets US rights to patent related to Traumakine
14 May 2021 - Faron Pharmaceuticals signs US sublicence agreement
14 May 2021 - EXECUTIVE CHANGES: Universe Group hires CFO as new CEO also joins
23 Apr 2021 - UK shareholder meetings calendar - next 7 days
16 Apr 2021 - TRADING UPDATES: Safestyle in strong start to 2021; Tandem ups payout
25 Mar 2021 - AIM WINNERS & LOSERS: Futura Medical shares rise on US FDA agreement
22 Mar 2021
Related News
IN BRIEF: Faron Pharmaceuticals fined EUR30,000 by Nasdaq Helsinki
Faron Pharmaceuticals Ltd - Turku, Finland-based cancer drug developer - Says the Disciplinary Committee of Nasdaq Helsinki Ltd has imposed an EUR30,0...
WINNERS & LOSERS: James Cropper sees earnings up; Block sells stake
(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Tuesday.
Faron Pharmaceuticals News
TRADING UPDATES: Wey takeover edges closer; Acorn in strategy switch
TRADING UPDATES: Wey takeover edges closer; Acorn in strategy switch
Faron Pharmaceuticals reports 'promising' data from drug study
(Sharecast News) - Clinical-stage biopharmaceutical company Faron Pharmaceuticals announced "promising" new data from its ongoing bexmarilimab 'MATINS...
Faron Pharmaceuticals gets US rights to patent related to Traumakine
Faron Pharmaceuticals gets US rights to patent related to Traumakine
Faron Pharmaceuticals signs US sublicence agreement
(Sharecast News) - Clinical-stage biopharmaceuticals company Faron Pharmaceuticals has signed a sublicence agreement for the rights to United States p...
EXECUTIVE CHANGES: Universe Group hires CFO as new CEO also joins
EXECUTIVE CHANGES: Universe Group hires CFO as new CEO also joins
UK shareholder meetings calendar - next 7 days
UK shareholder meetings calendar - next 7 days
TRADING UPDATES: Safestyle in strong start to 2021; Tandem ups payout
TRADING UPDATES: Safestyle in strong start to 2021; Tandem ups payout
AIM WINNERS & LOSERS: Futura Medical shares rise on US FDA agreement
AIM WINNERS & LOSERS: Futura Medical shares rise on US FDA agreement
Follow the stocks
